Notably, BRD4 pharmacological inhibition hampered the interaction between H2A.Z acetylation and BRD4, thus improving the transcriptional signature associated with schizophrenia in patient-derived neurons [192]. This evidence concerns the gene BRD4 and schizophrenia.